NeuroSense Therapeutics Ltd. Assets
NeuroSense Therapeutics Ltd. (NRSN) had Assets of $3.18 million as of 2023-12-31, per its 20-F filed 2024-04-04.
Discontinued › Notes
ifrs-full:Assets · last filed 2024-04-04
- 2023-12-31: Assets $3.18M.
- 2023-06-30: Assets $7.87M.
- 2022-12-31: Assets $7.71M.
- 2022-06-30: Assets $11.45M.
| Period end | Assets |
|---|---|
| 2023-12-31 | $3.18M 20-F · filed 2024-04-04 |
| 2023-06-30 | $7.87M 6-K · filed 2023-08-16 |
| 2022-12-31 | $7.71M 20-F · filed 2024-04-04 |
| 2022-06-30 | $11.45M 6-K/A · filed 2023-01-19 |
| 2021-12-31 | $11.43M 20-F · filed 2023-03-22 |
| 2020-12-31 | $779.00K 20-F · filed 2022-04-14 |